D. E. Shaw & Co., Inc. Incyte Corp Transaction History
D. E. Shaw & Co., Inc.
- $100 Billion
- Q1 2025
A detailed history of D. E. Shaw & Co., Inc. transactions in Incyte Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 862,595 shares of INCY stock, worth $60.3 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
862,595
Previous 576,540
49.62%
Holding current value
$60.3 Million
Previous $39.8 Million
31.16%
% of portfolio
0.05%
Previous 0.03%
Shares
29 transactions
Others Institutions Holding INCY
# of Institutions
695Shares Held
194MCall Options Held
564KPut Options Held
331K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.15 Billion22.18% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.49 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$1.4 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.9MShares$1.04 Billion0.55% of portfolio
-
State Street Corp Boston, MA10MShares$701 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $15.5B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...